These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9635475)
1. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. Sekijima Y; Ikeda S; Tokuda T; Satoh S; Hidaka H; Hidaka E; Ishikawa M; Yanagisawa N Eur Neurol; 1998; 39(4):234-7. PubMed ID: 9635475 [TBL] [Abstract][Full Text] [Related]
2. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing. van Gool WA; Evenhuis HM; van Duijn CM Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070 [TBL] [Abstract][Full Text] [Related]
3. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome. Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E allele distribution in parents of Down's syndrome children. Avramopoulos D; Mikkelsen M; Vassilopoulos D; Grigoriadou M; Petersen MB Lancet; 1996 Mar; 347(9005):862-5. PubMed ID: 8622392 [TBL] [Abstract][Full Text] [Related]
6. The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. Del Bo R; Comi GP; Bresolin N; Castelli E; Conti E; Degiuli A; Ausenda CD; Scarlato G J Neurol Sci; 1997 Jan; 145(1):87-91. PubMed ID: 9073034 [TBL] [Abstract][Full Text] [Related]
7. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. Bowirrat A; Friedland RP; Farrer L; Baldwin C; Korczyn A J Mol Neurosci; 2002; 19(1-2):239-45. PubMed ID: 12212789 [TBL] [Abstract][Full Text] [Related]
8. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome. Schupf N; Kapell D; Lee JH; Zigman W; Canto B; Tycko B; Mayeux R Ann Neurol; 1996 Nov; 40(5):799-801. PubMed ID: 8957023 [TBL] [Abstract][Full Text] [Related]
9. The impact of apolipoprotein E on dementia in persons with Down's syndrome. Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Arias-Vasquez A; Sayed-Tabatabaei FA; Vergeer-Drop J; Eikelenboom P; van Gool WA; van Duijn CM Neurobiol Aging; 2008 Jun; 29(6):828-35. PubMed ID: 17250929 [TBL] [Abstract][Full Text] [Related]
10. A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. Tyrrell J; Cosgrave M; Hawi Z; McPherson J; O'Brien C; McCalvert J; McLaughlin M; Lawlor B; Gill M Biol Psychiatry; 1998 Mar; 43(6):397-400. PubMed ID: 9532343 [TBL] [Abstract][Full Text] [Related]
11. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. Lai F; Kammann E; Rebeck GW; Anderson A; Chen Y; Nixon RA Neurology; 1999 Jul; 53(2):331-6. PubMed ID: 10430422 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan. Nakayama S; Kuzuhara S Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744 [TBL] [Abstract][Full Text] [Related]
13. Earlier onset of Alzheimer's disease in men with Down syndrome. Schupf N; Kapell D; Nightingale B; Rodriguez A; Tycko B; Mayeux R Neurology; 1998 Apr; 50(4):991-5. PubMed ID: 9566384 [TBL] [Abstract][Full Text] [Related]
14. Epidemiologic and genetic studies of dementia of the alzheimer type in japan. Urakami K; Adachi Y; Wakutani Y; Isoe K; Ji Y; Takahashi K; Nakashima K Dement Geriatr Cogn Disord; 1998; 9(5):294-8. PubMed ID: 9701681 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609 [TBL] [Abstract][Full Text] [Related]
16. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Martins RN; Clarnette R; Fisher C; Broe GA; Brooks WS; Montgomery P; Gandy SE Neuroreport; 1995 Jul; 6(11):1513-6. PubMed ID: 7579137 [TBL] [Abstract][Full Text] [Related]
17. Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome. Sliger M; Lander T; Murphy C J Alzheimers Dis; 2004 Aug; 6(4):397-402; discussion 443-9. PubMed ID: 15345810 [TBL] [Abstract][Full Text] [Related]
18. Little evidence of reduced survival to adulthood of apoE epsilon4 homozygotes in Down's syndrome. Edland SD; Wijsman EM; Schoder-Ehri GL; Leverenz JB Neuroreport; 1997 Nov; 8(16):3463-5. PubMed ID: 9427308 [TBL] [Abstract][Full Text] [Related]
19. Genetic and host factors for dementia in Down's syndrome. Schupf N; Sergievsky GH Br J Psychiatry; 2002 May; 180():405-10. PubMed ID: 11983636 [TBL] [Abstract][Full Text] [Related]
20. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]